{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T23:52:26Z","timestamp":1726012346597},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>This study assesses the value of image fusion using 18F-fluoro-L-DOPA (18F-DOPA) positron emission tomography (PET) and magnetic resonance imaging (MRI) for examining patients with neuroendocrine tumors (NETs) and a suspicion of metastasis of the liver.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Eleven patients (five women and six men aged between 20 and 81, with a mean age of 54.6\u2009years) were included in the study. All patients underwent whole-body 18F-DOPA PET examinations and contrast-enhanced MRI with diffusion-weighted sequences (DWS). Image fusion was performed using a semiautomatic voxel-based algorithm. Images obtained using PET and MRI were assessed separately. Side-by-side evaluations of fused PET\/MRI images were also performed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>In total, 55 liver lesions (52 liver metastases and 3 benign lesions) were detected in the 11 patients. Sensitivity detection for liver lesions was higher when using PET\/CT than when using contrast-enhanced MRI without DWSs and lower than using MRI with DWSs. The sensitivity of PET\/MRI image fusion in the detection of liver metastasis was significantly higher than that of MRI with DWSs (<jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.05).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Images of the liver obtained using PET and MRI in patients with NETs exhibited characteristic features. These findings suggest that an appropriate combination of available imaging modalities can optimize patient evaluations.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12880-020-00424-z","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T08:05:47Z","timestamp":1582531547000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The impact of 18F-FDOPA-PET\/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract"],"prefix":"10.1186","volume":"20","author":[{"given":"O.","family":"Barachini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bernt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pirich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hergan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Zandieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"key":"424_CR1","first-page":"119","volume":"5","author":"EE Ilett","year":"2015","unstructured":"Ilett EE, et al. Neuroendocrine carcinomas of the gastroenteropancreatic system: a comprehensive review. Diagnostics (Basel, Switzerland). 2015;5:119\u201376.","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"424_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1530\/ERC-13-0125","volume":"21","author":"M Fraenkel","year":"2014","unstructured":"Fraenkel M, Kim M, Faggiano A, de Herder WW, Valk GD. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature. Endocr Relat Cancer. 2014;21:153\u201363.","journal-title":"Endocr Relat Cancer"},{"key":"424_CR3","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, et al. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063\u201372.","journal-title":"J Clin Oncol"},{"key":"424_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1055\/s-0031-1291307","volume":"43","author":"M Anlauf","year":"2011","unstructured":"Anlauf M. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification. Horm Metab Res. 2011;43:825\u201331.","journal-title":"Horm Metab Res"},{"key":"424_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000443167","volume":"103","author":"M Pavel","year":"2016","unstructured":"Pavel M, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103:172\u201385.","journal-title":"Neuroendocrinology"},{"key":"424_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1136\/gut.2009.204453","volume":"60","author":"CJ Auernhammer","year":"2011","unstructured":"Auernhammer CJ, Goke B. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum\/ileum and pancreatic origin. Gut. 2011;60:1009\u201321.","journal-title":"Gut"},{"issue":"3","key":"424_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000464292","volume":"105","author":"Stefano Partelli","year":"2017","unstructured":"Partelli S, et al. ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2017;7.105(3):255\u2013265. https:\/\/doi.org\/10.1159\/000464292.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"424_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000471880","volume":"105","author":"Marianne Pavel","year":"2017","unstructured":"Pavel M, et al. ENETS consensus guidelines for the standards of care in neuroendocrine neoplasms: systemic therapy - biotherapy and novel targeted agents. Neuroendocrinology. 2017;105(3):266\u2013280. https:\/\/doi.org\/10.1159\/000471880.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"424_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000473892","volume":"105","author":"Rocio Garcia-Carbonero","year":"2017","unstructured":"Garcia-Carbonero R, et al. ENETS consensus guidelines for the standards of care in neuroendocrine neoplasms. Systemic therapy 2: chemotherapy. Neuroendocrinology. 2017;105(3):281\u2013294. https:\/\/doi.org\/10.1159\/000473892.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"424_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000475526","volume":"105","author":"Rodney J. Hicks","year":"2017","unstructured":"Hicks RJ, et al. ENETS consensus guidelines for the standards of care in neuroendocrine neoplasia: peptide receptor radionuclide therapy with radiolabeled somatostatin analogues. Neuroendocrinology. 2017;105(3):295\u2013309. https:\/\/doi.org\/10.1159\/000475526.","journal-title":"Neuroendocrinology"},{"key":"424_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/RLI.0b013e3182a4eb4a","volume":"49","author":"M Armbruster","year":"2014","unstructured":"Armbruster M, et al. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography\/computed tomography. Investig Radiol. 2014;49:7\u201314.","journal-title":"Investig Radiol"},{"key":"424_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000446369","volume":"104","author":"F Moryoussef","year":"2017","unstructured":"Moryoussef F, et al. Impact of liver and whole-body diffusion-weighted MRI for neuroendocrine tumors on patient management: a pilot study. Neuroendocrinology. 2017;104:264\u201372.","journal-title":"Neuroendocrinology"},{"key":"424_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1148\/radiol.13121628","volume":"268","author":"G d'Assignies","year":"2013","unstructured":"d'Assignies G, et al. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging. Radiology. 2013;268:390\u20139.","journal-title":"Radiology"},{"key":"424_CR14","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s00261-012-9871-9","volume":"37","author":"V Rufini","year":"2012","unstructured":"Rufini V, et al. Role of PET\/CT in the functional imaging of endocrine pancreatic tumors. Abdom Imaging. 2012;37:1004\u201320.","journal-title":"Abdom Imaging"},{"key":"424_CR15","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1007\/s00259-011-1862-5","volume":"38","author":"HB Fiebrich","year":"2011","unstructured":"Fiebrich HB, de Jong JR, Kema IP, et al. Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour. Eur J Nucl Med Mol Imaging. 2011;38:1854\u201361.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"424_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2967\/jnumed.113.126896","volume":"55","author":"A Imperiale","year":"2014","unstructured":"Imperiale A, et al. 18F-fluorodihydroxyphenylalanine PET\/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation. J Nucl Med. 2014;55:367\u201372.","journal-title":"J Nucl Med"},{"key":"424_CR17","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S1470-2045(06)70801-4","volume":"7","author":"KP Koopmans","year":"2006","unstructured":"Koopmans KP, et al. Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncol. 2006;7:728\u201334.","journal-title":"Lancet Oncol"},{"key":"424_CR18","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1200\/JCO.2007.15.1126","volume":"26","author":"KP Koopmans","year":"2008","unstructured":"Koopmans KP, et al. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography. J Clin Oncol. 2008;26:1489\u201395.","journal-title":"J Clin Oncol"},{"key":"424_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s00330-011-2266-4","volume":"22","author":"NF Schreiter","year":"2012","unstructured":"Schreiter NF, et al. Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours. Eur Radiol. 2012;22:458\u201367.","journal-title":"Eur Radiol"},{"key":"424_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/RLI.0b013e3182871a7f","volume":"48","author":"KJ Beiderwellen","year":"2013","unstructured":"Beiderwellen KJ, et al. Simultaneous 68Ga-DOTATOC PET\/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results. Investig Radiol. 2013;48:273\u20139.","journal-title":"Investig Radiol"},{"key":"424_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/RLI.0b013e31828234d0","volume":"48","author":"FC Gaertner","year":"2013","unstructured":"Gaertner FC, et al. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography\/magnetic resonance in comparison with positron emission tomography\/computed tomography in patients with neuroendocrine tumors. Investig Radiol. 2013;48:263\u201372.","journal-title":"Investig Radiol"},{"key":"424_CR22","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s00261-015-0409-9","volume":"40","author":"TA Hope","year":"2015","unstructured":"Hope TA, et al. Simultaneous (68)Ga-DOTA-TOC PET\/MRI with gadoxetate disodium in patients with neuroendocrine tumor. Abdom Imaging. 2015;40:1432\u201340.","journal-title":"Abdom Imaging"},{"key":"424_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/0471445428","volume-title":"Statistical methods for rates and proportions","author":"JL Fleiss","year":"2003","unstructured":"Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. 3rd ed. Hoboken: Wiley; 2003.","edition":"3"},{"key":"424_CR24","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1007\/s00330-015-3615-5","volume":"25","author":"MH Yu","year":"2015","unstructured":"Yu MH, Lee JM, Hur BY, et al. Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy. Eur Radiol. 2015;25:2428\u201336.","journal-title":"Eur Radiol"},{"key":"424_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ejrad.2017.08.028","volume":"95","author":"L Grazioli","year":"2017","unstructured":"Grazioli L, Ambrosini R, Frittoli B, et al. Primary benign liver lesions. Eur J Radiol. 2017;95:378\u201398.","journal-title":"Eur J Radiol"},{"key":"424_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000479293","volume":"106","author":"M Ronot","year":"2018","unstructured":"Ronot M, Clift AK, Baum RP, Singh A, Kulkarni HR, Frilling A, Vilgrain V. Morphological and functional imaging for detecting and assessing the resectability of neuroendocrine liver metastases. Neuroendocrinology. 2018;106:74\u201388. https:\/\/doi.org\/10.1159\/000479293.","journal-title":"Neuroendocrinology"},{"key":"424_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clinimag.2018.02.004","volume":"51","author":"G Corrias","year":"2018","unstructured":"Corrias G, Monti S, Horvat N, et al. Imaging features of malignant abdominal neuroendocrine tumors with rare presentation. Clin Imaging. 2018;51:59\u201364.","journal-title":"Clin Imaging"},{"issue":"6","key":"424_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","volume":"31","author":"PE Kinahan","year":"2010","unstructured":"Kinahan PE, Fletcher JW. Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy. Semin Ultrasound CT MR. 2010;31(6):496\u2013505.","journal-title":"Semin Ultrasound CT MR"},{"issue":"7","key":"424_CR29","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3390\/jcm8071032","volume":"8","author":"L Carideo","year":"2019","unstructured":"Carideo L, Prosperi D, Panzuto F, et al. Role of combined [68Ga]Ga-DOTA-SST analogues and [18F] FDG PET\/CT in the management of GEP-NENs: a systematic review. J Clin Med. 2019;8(7):1032.","journal-title":"J Clin Med"},{"issue":"2","key":"424_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2217\/fon-2017-0393","volume":"14","author":"A Tirosh","year":"2018","unstructured":"Tirosh A, Kebebew E. The utility of 68Ga-DOTATATE positron-emission tomography\/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors. Future Oncol. 2018;14(2):111\u201322.","journal-title":"Future Oncol"},{"issue":"2","key":"424_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/s-0028-1112124","volume":"32","author":"B Beuthien-Baumann","year":"2009","unstructured":"Beuthien-Baumann B. 18F-DOPA-PET in neuroendocrine tumours (NET). Nuklearmediziner. 2009;32(2):131\u20134.","journal-title":"Nuklearmediziner"},{"issue":"2","key":"424_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1148\/radiology.220.2.r01au25373","volume":"220","author":"S Hoegerle","year":"2001","unstructured":"Hoegerle S, et al. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology. 2001;220(2):373\u201380.","journal-title":"Radiology"},{"issue":"2","key":"424_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/jmri.24363","volume":"40","author":"M Armbruster","year":"2014","unstructured":"Armbruster M, Zech CJ, Sourbron S, Ceelen F, Auernhammer CJ, Rist C, Haug A, Singnurkar A, Reiser MF, Sommer WH. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET\/CT compared in patients with liver metastases from neuroendocrine neoplasms. J Magn Reson Imaging. 2014;40(2):457\u201366.","journal-title":"J Magn Reson Imaging"},{"issue":"26","key":"424_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.4254\/wjh.v9.i26.1081","volume":"9","author":"A Shenoy-Bhangle","year":"2017","unstructured":"Shenoy-Bhangle A, Baliyan V, Kordbacheh H, Guimaraes AR, Kambadakone A. Diffusion weighted magnetic resonance imaging of liver: principles, clinical applications and recent updates. World J Hepatol. 2017;9(26):1081\u201391.","journal-title":"World J Hepatol"},{"key":"424_CR35","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1007\/s00330-016-4250-5","volume":"26","author":"V Vilgrain","year":"2016","unstructured":"Vilgrain V, Esvan M, Ronot M, Caumont-Prim A, Aub\u00e9 C, Chatellier G. A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. Eur Radiol. 2016;26:4595\u2013615.","journal-title":"Eur Radiol"},{"issue":"2","key":"424_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.crad.2016.10.021","volume":"72","author":"E Belousova","year":"2017","unstructured":"Belousova E, Karmazanovsky G, Kriger A, et al. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumor grades. Clin Radiol. 2017;72(2):150\u20138.","journal-title":"Clin Radiol"},{"key":"424_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejrad.2018.05.019","volume":"105","author":"B Kaltenbach","year":"2018","unstructured":"Kaltenbach B, Wichmann JL, Pfeifer S, et al. Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT. Eur J Radiol. 2018;105:20\u20134.","journal-title":"Eur J Radiol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-020-00424-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12880-020-00424-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-020-00424-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:18:41Z","timestamp":1614039521000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-020-00424-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["424"],"URL":"https:\/\/doi.org\/10.1186\/s12880-020-00424-z","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]},"assertion":[{"value":"22 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The local ethics committee of Vienna (Magistrat der Stadt Wien Magistratsabteilung 15) granted ethical approval for this study. Informed written consent was obtained from all the participants. This study conformed to the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}